Login
From:
Myeloma Research News
(Uncensored)
subscribe
Hard-to-treat multiple myeloma survival extended with Elrexfio treatment: Study
https://myelomaresearchnews.com/news/hard-to-treat-multiple-myeloma-survival-extended-with-elrexfio-treatment-study/
links
backlinks
Tagged with:
elrexfio
Roast topics
Find topics
Find it!
Median survival was 24.6 months, according to data from the 123 myeloma patients who took Elrexfio with the first group in MagnetisMM-3.
